Novavax, no-vax doctor: “It could be safer and more effective”

“If it is a protein vaccine that contains the attenuated or inactivated virus, it belongs to the category of older generation vaccines, which have been tested for hundreds of years: we certainly know what we are getting into, unlike these other vaccines we do not know which ones be the possible consequences at a distance. This is the substantial and very important difference. But I still have to study it and understand well how it is done, in order to pronounce myself “. So at Adnkronos Salute Mariano Amici, the Ardea doctor suspended without salary for his positions against the anti-Covid vaccines, on the new vaccine arriving in Italy this week. “As far as efficacy is concerned – says Amici – since it is a vaccine for a virus that mutates, it is always very relative because between the moment the virus is isolated, the vaccine is treated and produced, the virus has mutated, therefore the efficacy clearly decreases a lot. In any case in my opinion – he states – if it is a protein vaccine, it is still an efficacy superior to a gene vaccine because that takes only a small part of the virus while this protein, since it contains everything the virus produces antibodies for all parts of the virus and it is obvious that in the mutation some part of the virus remains the same and, therefore, the antibodies remain more effective. So in terms of safety and efficacy it is certainly far better than to the others”. So would you recommend it? “I always look at vaccines on mutable genes with a bit of a critical eye – brakes Amici – because the effectiveness is relative. And since the effectiveness is very relative and in any case the vaccine gives some risk, I don’t know exactly from which side the balance between risks and benefits. If with a vaccine for a non-mutable virus the balance between risks and benefits certainly hangs on the side of benefits, in this case – he concludes – they are either equal or more on the side of risks “.